Towards a genetic definition of cancer-associated inflammation: role of the IDO pathway
about
The indoleamine 2,3-dioxygenase (IDO) pathway controls allergyAnti-tumor immunity: myeloid leukocytes control the immune landscapePathological mobilization and activities of dendritic cells in tumor-bearing hosts: challenges and opportunities for immunotherapy of cancerMicrobial carcinogenic toxins and dietary anti-cancer protectants.Bin1 attenuation suppresses experimental colitis by enforcing intestinal barrier function.Immunological thought in the mainstream of cancer research: Past divorce, recent remarriage and elective affinities of the future.IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan.IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation.Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancerNovel Colitis Immunotherapy Targets Bin1 and Improves Colon Cell Barrier Function.Common polymorphism in the MMP-13 gene may contribute to the risk of human cancers: a meta-analysis.Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases.Cardiac and gastrointestinal liabilities caused by deficiency in the immune modulatory enzyme indoleamine 2,3-dioxygenaseImmunological and nonimmunological effects of indoleamine 2,3-dioxygenase on breast tumor growth and spontaneous metastasis formationHuman indoleamine 2,3-dioxygenase is a catalyst of physiological heme peroxidase reactions: implications for the inhibition of dioxygenase activity by hydrogen peroxide.Examining the relationship between diet-induced acidosis and cancer.Performance-enhanced mesenchymal stem cells via intracellular delivery of steroids.Individual differences in pre-carcinogen cytokine and corticosterone concentrations and depressive-like behavior predict tumor onset in rats exposed to a carcinogen.PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells.Cellular and molecular mechanisms in cancer immune escape: a comprehensive review.Initiation and execution mechanisms of necroptosis: an overview.Specific in situ detection of murine indoleamine 2, 3-dioxygenase.Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses.IDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastoma.Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models.Platform-independent gene expression signature differentiates sessile serrated adenomas/polyps and hyperplastic polyps of the colon.Cancer: Why tumours eat tryptophan.Inflammatory Reprogramming with IDO1 Inhibitors: Turning Immunologically Unresponsive 'Cold' Tumors 'Hot'.Obesity and Cancer: Existing and New Hypotheses for a Causal Connection.Low indoleamine 2,3-dioxygenase activity in persistent food allergy in children.The expression and prognostic relevance of indoleamine 2,3-dioxygenase in tongue squamous cell carcinoma.Indoleamine 2,3-dioxygenase expression in early keratocyte neoplasia of the lower lip correlates to the degree of cell atypia.The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppression.
P2860
Q26822976-60540B60-DA99-4CB5-A18D-ECFE33207B0FQ28390573-6D9B5C4A-4B24-4545-9670-63FD2F2D964FQ28392626-6EA0C4B5-7831-41D9-89CA-510E38AE5009Q33844512-C606B423-BE48-4D23-800D-D7093B189BC4Q34270337-2B5EE13E-0C7A-4FAE-8A36-4B8A8F53CBA8Q34312571-60CB2DF6-93A2-4DFF-9A94-00037E9F8E9FQ34319398-F50EA351-02D8-4671-9947-5BBB5EA1F14AQ34396547-69DB3A60-CCF1-4313-91AC-C9FC5C092F23Q34414152-A2F9F2F2-0DFC-4E1B-BB33-56B0328A7411Q34486064-E7AFDB9B-6D54-4A39-A679-EBF2E898C2B3Q35206743-3D3CD033-DB8A-4E90-8125-C7E81614305CQ35261110-02245482-45AD-48C6-919B-07C0B68853C0Q35911231-EDD76760-ED10-4B69-8C8F-EE660B483C10Q35986384-03A2C7B6-8E81-4F3E-B4BF-A9E13F6FB9EEQ36543996-F6326676-FCA1-413F-94AF-F02778839655Q36608481-1F9D21C5-BE70-4F89-B7EB-6F4592991594Q37695489-70CB3A12-6B48-4F53-9B88-F6D20C715F74Q37708508-7E26159C-2E5E-4E4B-BAD2-37CB233FEC43Q38047052-30F29D67-2761-4331-8ABB-2B8571A212A7Q38170150-EB8D4C60-7266-42A0-8E41-D44DEADE874AQ39302537-65504C5A-25CC-4E6F-A316-031320C13E79Q39956064-BE106FC1-D529-44D9-BA65-C039E94F098FQ41812172-14AAF2B6-C652-4886-A999-BB49330119F4Q42324668-C3DA43ED-2864-4C35-A018-35A5CE264E66Q42965305-383C1A6E-107E-4B93-9A4B-01A20BB31FC2Q47111568-50357273-FDD2-48B7-B056-C832702A1768Q48846863-9A711280-73EC-4DF0-8B24-78BA5E52C03FQ50138585-923B4EF2-1A7C-442B-B852-983BD8046DE1Q52662023-014CDA56-7C05-4C97-9772-504631759B75Q52911349-86250ABF-F119-4309-AB5C-E6BD60FAA970Q53146697-3B06D7A8-41B9-46E5-A8E0-365682837A69Q53275838-0D714BFB-AD64-40F2-99C3-67D230D6BB28Q54372448-821A3787-7A3D-4951-8843-5DA9C36A21CA
P2860
Towards a genetic definition of cancer-associated inflammation: role of the IDO pathway
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Towards a genetic definition of cancer-associated inflammation: role of the IDO pathway
@ast
Towards a genetic definition of cancer-associated inflammation: role of the IDO pathway
@en
type
label
Towards a genetic definition of cancer-associated inflammation: role of the IDO pathway
@ast
Towards a genetic definition of cancer-associated inflammation: role of the IDO pathway
@en
prefLabel
Towards a genetic definition of cancer-associated inflammation: role of the IDO pathway
@ast
Towards a genetic definition of cancer-associated inflammation: role of the IDO pathway
@en
P2093
P2860
P1476
Towards a genetic definition of cancer-associated inflammation: role of the IDO pathway
@en
P2093
Alexander J Muller
George C Prendergast
Richard Metz
P2860
P304
P356
10.2353/AJPATH.2010.091173
P407
P577
2010-03-12T00:00:00Z